The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Our model allows us to work with top talent across disciplines beyond our six centers.
Open in Twitter
Parker Institute
@parkerici
Swedish scientists launch #cancer gene “atlas” to predict patients survival from @emilylmullin @techreview https://t.co/4PJAIpslJQ
21 hours ago
Parker Institute
@parkerici
Swedish scientists launch #cancer gene “atlas” to predict patients survival from @emilylmullin @techreview https://t.co/4PJAIpslJQ
21 hours ago
Open in Twitter
Parker Institute
@parkerici
RT @CancerResearch: How immunotherapy is influencing clinical trial design for #cancer treatments: https://t.co/MusGR6CJeA
22 hours ago
Parker Institute
@parkerici
RT @CancerResearch: How immunotherapy is influencing clinical trial design for #cancer treatments: https://t.co/MusGR6CJeA
22 hours ago
Open in Twitter
Parker Institute
@parkerici
PD-L1 #immunotherapy target turns out to have a surprising buddy, a previously unexplored molecule @NKI_nl @nature https://t.co/0Y4eTkjNsu
1 day ago
Parker Institute
@parkerici
PD-L1 #immunotherapy target turns out to have a surprising buddy, a previously unexplored molecule @NKI_nl @nature https://t.co/0Y4eTkjNsu
1 day ago